A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Sagar Lonial; Niels Van de Donk; Rakesh Popat; Jeffrey A. Zonder; Monique Minnema; Jeremy T. Larsen; Tuong Vi Nguyen; Min S. Chen; Amine Bensmaine; Teresa Peluso; Pieter Sonneveld

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Sagar Lonial, Niels Van de Donk, Rakesh Popat, Jeffrey A. Zonder, Monique Minnema, Jeremy T. Larsen, Tuong Vi Nguyen, Min S. Chen, Amine Bensmaine, Teresa Peluso, Pieter Sonneveld

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	E52-E53
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	19
Issue number	10
Publication status	Published - Oct 2019

Keywords

clinical trials
immunomodulatory drugs
Relapsed Refractory MM

Cite this

@article{2a6068f44e8e4945b20a00868ba3861b,

title = "A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma",

keywords = "clinical trials, immunomodulatory drugs, Relapsed Refractory MM",

author = "Sagar Lonial and {Van de Donk}, Niels and Rakesh Popat and Zonder, {Jeffrey A.} and Monique Minnema and Larsen, {Jeremy T.} and {Tuong Vi Nguyen} and Chen, {Min S.} and Amine Bensmaine and Teresa Peluso and Pieter Sonneveld",

year = "2019",

month = oct,

language = "English",

volume = "19",

pages = "E52--E53",

number = "10",

}

TY - JOUR

T1 - A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

AU - Lonial, Sagar

AU - Van de Donk, Niels

AU - Popat, Rakesh

AU - Zonder, Jeffrey A.

AU - Minnema, Monique

AU - Larsen, Jeremy T.

AU - Tuong Vi Nguyen,

AU - Chen, Min S.

AU - Bensmaine, Amine

AU - Peluso, Teresa

AU - Sonneveld, Pieter

PY - 2019/10

Y1 - 2019/10

KW - clinical trials

KW - immunomodulatory drugs

KW - Relapsed Refractory MM

M3 - Meeting Abstract

SN - 2152-2650

VL - 19

SP - E52-E53

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 10

ER -